Unlock instant, AI-driven research and patent intelligence for your innovation.
1,2,4-Triazolone Derivative
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of triazolone and derivatives, applied in the field of 1,2,4-triazolone derivatives
Active Publication Date: 2013-05-22
TAISHO PHARMACEUTICAL CO LTD
View PDF26 Cites 4 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, there is no report on the compounds with 1,2,4-triazolone skeleton disclosed in the present invention
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment
[0285] Hereinafter, reference examples, examples, and test examples are given to further describe the present invention in detail, but these do not limit the present invention and can be changed without departing from the scope of the present invention.
[0286] In Reference Examples and Examples, the "phase separator (Phase Separator)" used in the post-treatment refers to Biotage's ISOLUTE (registered trademark) phase separator. For "SNAP Cartridge KP-NH" purified by column chromatography, Biotage SNAPCartridge KP-NH was used, "SNAP Cartridge KP-Sil" was Biotage SNAPCartridge KP-Sil, and "SNAP Cartridge HP-Sil" was Biotage The company's SNAPCartridge HP-Sil, "Chromatorex NH" uses Cromatrex (registered trademark) NH manufactured by Fuji Silysia Chemical Co., Ltd. For purification using preparative thin layerchromatography (PTLC), Mercury silica gel 60F was used 254 , 20cm×20cm. Waters Sunfire prep C18 OBD, 5.0 μm, φ30×50 mm was used for “reversed phase column chromatography...
reference example P-A1
[0317] ?Reference Example P-A1: Synthesis of (3-chlorophenyl)(oxo)acetic acid
[0318] [chemical 18]
[0319]
[0320] In (3-chlorophenyl)(oxo)ethyl acetate (2.00g) in THF / MeOH solution (1:1) (48ml), add 2mol / L NaOH aqueous solution (24ml) under ice-cooling, at room temperature Stir overnight. After the solvent was distilled off under reduced pressure, a 3 mol / L HCl aqueous solution was added under ice-cooling. The precipitated solid was collected by filtration to obtain the title compound (2.00 g, colorless solid).
[0321] MS (ESI neg.) m / z : 183([M-H] - ).
[0322] The following compounds were synthesized by the same method as in Reference Example P-A1.
[0323] ?Reference Example P-A2: (3-Chloro-4-fluorophenyl)(oxo)acetic acid
[0324] [Synthesis from ethyl (3-chloro-4-fluorophenyl)(oxo)acetate]
[0325] [chemical 19]
[0326] .
reference example P-A3
[0327] ?Reference Example P-A3: Synthesis of (3-methoxyphenyl)(oxo)acetic acid
[0328] [chemical 20]
[0329]
[0330] A pyridine solution (27 ml) of 1-(3-methoxyphenyl)ethanone (8.00 g) and selenium dioxide (8.87 g) was stirred at an external temperature of 100°C for 4 hours. After standing to cool, the reaction liquid was filtered through Celait (registered trademark), diluted with EtOAc, washed with 1mol / L HCl aqueous solution and brine, and washed with Na 2 SO 4 to dry. The solvent was distilled off under reduced pressure to obtain the title compound (10.6 g, gray solid).
[0331] MS (ESI neg.) m / z : 179([M-H] - ).
[0332] The following compounds were synthesized by the same method as in Reference Example P-A3.
[0333] ?Reference Example P-A4: (4-fluoro-3-methoxyphenyl)(oxo)acetic acid
[0334] [Synthesis from 1-(4-fluoro-3-methoxyphenyl)ethanone]
[0335] [chem 21]
[0336]
[0337] MS (ESI neg.) m / z : 197([M-H] - ).
[0338] ?Reference Example P-A5: (...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
technical field [0001] The present invention relates to a compound of 1,2,4-triazolone skeleton having antagonistic effect on the V1b receptor of argininevasopressin (AVP) and a pharmaceutical composition containing the compound as an active ingredient, in particular to affective disorders, Anxiety disorder, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, eating disorder, hypertension, digestive organ disease, drug dependence, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, head Therapeutic or preventive agents for diseases such as trauma, inflammation, immune-related diseases, and alopecia. Background technique [0002] Argininevasopressin (AVP) is a peptide composed of 9 amino acids. It is mainly biosynthesized in the hypothalamus. As a pituitary hormone, it is highly involved in the regulation of plasmaosmotic pressure, blood pressure and body fluid volume. [0003] As for the AVP receptor, three subtypes of V1a, V1b, a...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.